Global Influenza Vaccine Market Evolving Trends and Opportunities in COVID-19 pandamic end by 2030 from Sachin's blog

The Global Influenza Vaccine Market was valued at USD 6.65 Billion in 2022 and is projected to reach USD 11.42 Billion by 2030, registering a CAGR of 6.80% for the forecast period 2023-2030.

 

The Influenza Vaccine Market size study shifts its attention to in-depth business challenges, defined investment opportunities, market share coupled with product type and applications, key companies responsible for the production, and upcoming market opportunities.

 

Get Free Exclusive Sample of this Premium Report at: https://isayresearch.com/sample/2157

 

The report aims to offer a comprehensive analysis on the global Influenza Vaccine market. It concentrates on the market dynamics, technological inclinations, and understandings on different end-user industries and product types. Additionally, it examines the key players and the competitive landscape in the global Influenza Vaccine market.

 

List of Prominent Players: 

 

  • Biodiem Ltd
  • Sanofi
  • AstraZeneca Plc (AstraZeneca)
  • Hoffmann-La Roche Ltd.
  • Merck & Co., Inc. (Merck Sharp & Dohme Corp.)
  • Emergent BioSolutions Inc.
  • Pfizer, Inc.
  • CSL Limited (Seqirus Gmbh)
  • GlaxoSmithKline Plc
  • Gamma Vaccines Pty Ltd
 Segmentation of Global Influenza Vaccine Market: By Vaccine Type
  • Inactivated
  • Live Attenuated
  • By Indication
  • Trivalent
  • Quadrivalent
 By Age Group
  • Adult
  • Pediatric
  • By Route of Administration
  • Injection
  • Nasal Spray
 By Distribution Channel
  • Hospitals & Pharmacies
  • Government & Institutional Supply
  • Other

 

Market segment by Region, regional analysis covers

 

North America (United States, Canada and Mexico)

Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)

Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)

South America (Brazil, Argentina, Colombia, and Rest of South America)

Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

 

Report Target Clients:

 

Investors and Private Equity Firms

Influenza Vaccine Providers

Suppliers as well as Distributors

Government and Regulatory Agencies

End users

 

Read Summary Of the report @ https://isayresearch.com/report/2157/global-influenza-vaccine-market/

 

Company Profile

 

iSay Research is a leading market research company dedicated to providing comprehensive and actionable insights to businesses across various industries. With a focus on delivering accurate data and analysis, we help companies make informed decisions and stay ahead in today's dynamic market landscape.

 

Contact

 

iSay Solutions LLC

166 Geary St. 

15th Floor Suite #212, 

San Francisco, California 94108, 

United States


Previous post     
     Next post
     Blog home

The Wall

No comments
You need to sign in to comment